Neurodegenerative Diseases

Agid Y. (1991). “Parkinson's disease: Pathophysiology.” Lancet 337:1321–1324.

Amaducci L. Lippi A. (1988). “Risk factors and genetic background for Alzheimer's disease.” Acta Neurol. Scand. Suppl. 116:13–18.

Anderson D.W. Schoenberg B.S. Haerer A.F. (1988). “Prevalence surveys of neurologic disorders: Methodologic implications of the Copiah County Study.” J. Clin. Epidemiol. 41:339–345.

Appel S.H. (1981). “A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism, and Alzheimer's disease.” Ann. Neurol. 10(6):499–505.

Baker F.M. (1992). “Ethnic minority elders: A mental health research agenda.” Hosp. and Commun. Psychiat. 43:337–342.

Baker S.R. Rogul M. (eds.). (1985). Environmental Toxicity and the Aging Process. Alan R. Liss, New York.

Barbeau A. Roy M. Cloutier T. Plasse L. Paris S. (1986). “Environmental and genetic factors in the etiology of Parkinson's disease.” Adv. Neurol. 45:299–306.

Barbeau A. Roy M. Bernier G. Campanella G. Paris S. (1987). “Ecogenetics of Parkinson's disease: Prevalence and environmental aspects in rural areas.” Can. J. Neurol. Sci. 14:36–41.

Benvenuti F. Baroni A. Bandinelli S. Ferrucci L. Carradetti R. Pantealeo T. (1988). “Flunarizine-induced parkinsonism in the elderly.” J. Clin. Pharmacol. 28:600–608.

Bhakrucha N.E. Stokes L. Schoenberg B.S. Ward C. Ince S. Nutt J.G. Elderidge R. Calne D.B. Mantel N. Duvoisin R. (1986). “A case-control study of twin pairs discordant for Parkinson's disease: A search for environmental risk factors.” Neurol. 36:284–288.

Bird T.D. Schellenberg G.D. Wijsman E.M. Martin G.M. (1989). “Evidence for etiologic heterogeneity in Alzheimer's disease.” Neurobiol. Aging 10:432–438.

Boothby J.A. DeJesus P.V. Rowland L.P. (1974). “Reversible forms of motor neuron disease—Lead neuritis.” Arch. Neurol. 31:18–23.

Breitner J.C. Magruder-Habib K.M. (1989). “Criteria for onset critically influence the estimation of familial risk in Alzheimer's disease.” Genet. Epidemiol. 6:663–669.

Brooks D.J. (1991). “Determination of preclinical Parkinson's disease with PET.” Neurol. 41:24–27.

Burns A. Luthert P. Levy R. Jacoby R. Lantos P. (1990). “Accuracy of clinical diagnosis of Alzheimer's disease.” Br. Med. J. 301:1026–1026.

Calne D.B. (1975). Therapeutics in Neurology. Blackwell, Oxford.

Calne D.B. (1988). “Options for the etiology of Parkinson's disease: The association with dementia.” Mt. Sinai J. Med. 55:58–61.

Calne D.B. (1989). “Is ‘Parkinson's disease’ one disease?” J. Neurol. Neurosurg. Psychiat. Suppl. 4:18–21.

Calne D.B. McGreer E. Eisen A. Spencer P. (1986). “Alzheimer's disease, Parkinson's disease and motoneuron disease: Abiotopic interaction between aging and environment?” Lancet 2:1067–1070.

Conradi S. Ronnevi L.O. Norris F.H. (1982). “Motor neuron disease and toxic metals.” Adv. Neurol. 36:201–231.

Cooper B. (1991). “The epidemiology of primary degenerative dementia and related neurological disorders.” Eur. Arch. Psychiat. Clin. Neurosci. 240:223–233.

Crapper MCLachlan D.R. Krishman S. Quittkat S. (1976). “Aluminum, neurofibrillary degeneration and Alzheimer's disease.” Brain 99:67–80.

Crapper MCLachlan D.R. (1986). “Aluminum and Alzheimer's disease.” Neurobiol. Aging 7:525–532.

Cummings J. Benson D.F. Loverme S. (1980). “Reversible dementia: ///Illustrative cases, definitions, and review.” J. Amer. Med. Assoc. 243:2434–2439.

Cummings R.G. Leeder S.R. (1988). “The changing face of neurological disease 1946–1987: An epidemiological perspective.” Austr. N.Z. J. Med. 18:881–889.

Currier R.D. Haerer A.F. (1968). “Amyotrophic lateral sclerosis and metallic toxins.” Arch. Environ. Health 17:712–719.

DaVies I. (1986). “Aluminum, neurotoxicology and dementia.” Rev. Environ. Health 6:251–296.

Diamond S.G. Markham C.H. Hoen M.M. McDowell F. Muenter M.D. (1990). “An examination of male-female differences in progression and mortality of Parkinson's disease.” Neurol. 40:763–766.

DePedro-Cuesta J. Litvan I. (1991). “Epidemiology of motor neuron disease.” In: Neuroepidemiology ( Anderson D.W. , ed.). CRC Press: Boca Raton, Fl., pp. 265–296.

Doll R. Peto R. (1981). “The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today.” JNCI 66:1191–1208.

Drachman D.B. Kuncl R.W. (1989). “Amyotrophic lateral sclerosis: An unconventional autoimmune disease?” Ann. Neurol. 26:269–274.

Evans D.A. Funkenstein H.H. Albert M.S. Scherr P.A. Cook N.R. Chown M.J. Hebert L.E. Hennikens C.H. Taylor J.O. (1989). “Prevalence of Alzheimer's disease in a community population of older persons.” J. Amer. Med. Assoc. 262:2551–2556.

Farrer L.A. O'Sullivan D.M. Cupples C.A. Growdon J.H. Myers R.H. (1989). “Assessment of genetic risk for Alzheimer's disease among first degree relatives.” Ann. Neurol. 25:485–493.

Freed D.M. Kandel E. (1988). “Longterm occupational exposure and the diagnosis of dementia.” Neurotoxicol. 9:391–400.

Gadjusek D.C. (1990). “Cycad toxicity not the cause of high-incidence amoytrophic lateral sclerosis/parkinsonism/dementia on Guam, Kii peninsula of Japan, or in west New Guinea.” In: Concepts in Pathogenesis and Etiology, pp. 317–325.

Ganrot P.O. (1986). “Metabolism and possible health effects of aluminum.” Environ. Health Perspect. 65:363–441.

Garruto R.M. Gajdusek D.C Chen K.M. (1980). “Amyotrophic lateral sclerosis among Chamorro migrants from Guam.” Ann. Neurol. 8:612–619.

Gibb W.R. (1989). “Dementia and Parkinson's disease.” Br. J. Psychiat. 154:596–614.

Gilleard C.J. Kellett J.M. Coles J.A. Millard P.H. Honavar M. Lantos P.L. (1992). “The St. George's dementia bed investigation study: A comparison of clinical and pathological diagnosis.” Acta. Psychiat. Scand. 85:254–269.

Goldman B. (1991). The Truth About Where You Live. Times Books, New York.

Goldsmith J.R. Herishanu Y. Abarbanel J.M. Weinbaum Z. (1990). “Clustering of Parkinson's disease points to environmental etiology.” Arch. Environ. Health 45:88–94.

Graham D.G. (1984). “Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease.” Neurotoxicol. 5:83–95.

Granieri E. Carreras M. Tola R. (1988). “Motor neuron disease in the province of Ferrara, Italy, in 1964–1982.” Neurol. 38:1604–1608.

Gresham L.S. Molgaard C.A. Goldbeck A.L. Smith R. (1986). “Amyotrophic lateral sclerosis and occupational heavy metal exposure: A case-control study.” Neuroepidemiol. 5:29–38.

Guy S.P. Jones D. Mann D.M.A. Itzhaki R.F. (1991). “Human neuroblastoma cells treated with aluminum express an epitope associated with Alzheimer's disease neurofibrillary tangles.” Neurosci. Lett. 121:166–168.

Haerer A.F. Anderson D.W. Schoenberg B.S. (1987). “Survey of major neurologic disorders in a biracial United States population: The Copiah County Study.” South Med. J. 80:339–343.

Hawkes C.H. Cavanagh J.B. Fox A.J. (1989). “Motoneuron disease: A disorder secondary to solvent exposure?” Lancet I: 73–76.

Ho D.D. Bredesen D.E. Vinters H.V. Daar E.S. (1989). “The acquired immunodeficiency syndrome (AIDS) dementia-complex.” Ann. Intern. Med. 111: 400–410.

Hoffman P.M. Brody J.A. (1971). “The reliability of death certificate reporting for amyotrophic lateral sclerosis.” J. Chronic Dis. 24: 5–8.

Horner R.D. (1987). “Age at onset of Alzheimer's disease: Clue to the relative importance of etiologic factors?” Am. J. Epidemiol. 126: 409–414.

Hornykiewicz O. (1989). “Aging and neurotoxins as causative factors in idiopathic Parkinson's disease—A critical analysis of the neurochemical evidence.” Prog. Neuropsychopharmacol. Biol. Psychiat. 13(3–4):319–328.

Huber S.J. Chakeres D.W. Paulson G.W. Khanna R. (1990). “Magnetic resonance imaging in Parkinson's disease.” Arch. Neurol. 47(7):735–737.

Hudson A.J. (1981). “Amyotrophic lateral sclerosis and its association with dementia, Parkinsonism and other neurological disorders: A review.” Brain 104:217–247.

Hughes J.T. (1982). “Pathology of amyotrophic lateral sclerosis.” In: Human Motor Neuron Diseases ( Rowland L. , ed.). New York: Raven Press, pp. 61–74.

Jankovic J. McDermott M. Carter J. Gauthier S. Goetz C. Golbe L. Huber S. Koller W. Olanow C. Shoulson I. Stern M. Tanner C. Weiner, W. (Parkinson Study Group) (1990). “Variable expression of Parkinson's disease: A base-line analysis of the DATATOP cohort.” Neurol. 40(10):1529–1534.

Katzman R. Terry R.D. (eds.). (1983). The Neurology of Aging. F.A. Davis, Philadelphia.

Kennedy P.G.E. (1990). “On the possible role of viruses in the etiology of motor neurone disease. A review.” J. R. Soc. Med. 83(12):784–787.

Klawans H.L. (1973). The Pharmacology of Extrapyramidal Movement Disorders. S. Karger, Basel.

Klawans H.L. Stein R.W. Tanner C.M. Goetz C.G. (1982). “A pure parkinsonian syndrome following acute carbon monoxide intoxication.” Arch. Neurol. 39:302–304.

Kopin I.J. (1987). “MPTP: An industrial chemical and the contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease.” Environ. Health Perspect. Nov. 75:45–51.

Kokmen E. Chandra V. Schoenberg B.C. (1988). “Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960–1974.” Neurol. 38:375–380.

Kurland L.T. (1978). “Geographic isolates: Their role in neuroepidemiology.” Adv. Neurol. 19:69–82.

Kurlander H.M. Patten B.M. (1979). “Metals in spinal cord tissue of patients dying of motor neuron disease.” Ann. Neurol. 6:21–24.

Landrigan P.J. Baker D.B. (1991). “The recognition and control of occupational disease.” J. Amer. Med. Assoc. 266(5):676–680.

Lane R.J. Routledge P. (1983). “Drug induced neurological disorders.” Drugs 26:124–147.

Langston J.W. (1985). “MPTP neurotoxicity: An overview and characterization of phases of toxicity.” Life Sci. 36:201–206.

Langston J.W. Ballard P. Tetrud J.W. (1983). “Chronic Parkinsonism in humans due to a product of meperidine analog synthesis.” Science 219:979–980.

Langston J.W. Irwin I. Ricaurte G.A. (1987). “Neurotoxins, Parkinsonism and Parkinson's Disease.” Pharmacol. Ther. 32:19–49.

Langston J.W. Koller W.C. (1991). “The next frontier in Parkinson's disease: Presymptomatic detection.” Neurol. 41:5–7.

Leverenz J. Sumi S.M. (1986). “Parkinson's disease in patients with Alzheimer's disease.” Arch. Neurol. 43(7):662–664.

Lilienfeld D.E. Chan E. Ehland J. (1989). “Rising mortality from motoneuron disease in the USA, 1962–84.” Lancet 1:710–713.

Lilienfeld D.E. Chan E. Ehland J. Godbold J. Landrigan P.J. Marsh G. Perl D.P. (1990). “Two decades of increasing mortality from Parkinson's disease among the U.S. elderly.” Arch. Neurol. 47:731–734.

Livesley B. Sissons C.E. (1968). “Chronic lead intoxication mimicking motor neurone disease.” (Letter). Br. Med. J. 4:387–388.

Lobo A. Dewey M. Copeland J. Dia J.L. Saz P. (1992). “The prevalence of dementia among elderly people living in Zaragoza and Liverpool.” Psychol. Med. 22:239–243.

Lopez O.L. Swihart A.A. Becker J.T. Reinmuth O.M. Reynolds C.F. III Rezek D.L. Daly F.L. III (1990). “Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease.” Neurol. 40:1517–1522.

Mandybur T.I. Cooper G.P. (1979). “Increased spinal cord lead content in amytrophic lateral sclerosis: Possibly a secondary phenomenon.” Med. Hypoth. 5:1313–1315.

Marttila R.J. Rinne U.K. (1989). “Epidemiological approaches to the etiology of Parkinson's disease.” Acta. Neurol. Scan. Suppl. 126:13–18.

McGeer P.L. Itagaki S. Akiyama H. McGeer E.F. (1988). “Rate of cell death in parkinsonism indicates active neuropathological process.” Ann. Neurol. 24:574–576.

Mitchell J.D. (1987). “Heavy metals and trace elements in amyotrophic lateral sclerosis.” Neurol. Clin. 5:43–60.

Murden R.A. (1990). “The diagnosis of Alzheimer's disease.” Adv. Exp. Med Biol. 282:59–64.

National Research Council (NRC). (1987). Aging in Today's Environment. NAS Press, Washington, D.C.

National Research Council (NRC). (1992). Environmental Neurotoxicology. NAS Press, Washington, D.C.

Office of Technology Assessment (OTA). (1987). Losing a Million Minds. Confronting the Tragedy of Alzheimer's Disease and Other Dementias. United States Government Printing Office, Washington, D.C.

Office of Technology Assessment (OTA). (1990a). Neurotoxicity. United States Government Printing Office, Washington, D.C.

Office of Technology Assessment (OTA). (1990b). Confused Minds, Burdened Families. United States Government Printing Office, Washington, D.C.

Ohlson C.G. Hogstedt C. (1981). “Parkinson's disease and occupational exposure to organic solvents, agricultural chemicals and mercury—A case-referent study.” Scand. J. Work Environ. Health 7: 252–256.

Pall H.A. Williams A.C. Waring R. Elias E. (1987). “Motor neurone disease as manifestation of pesticide toxicity.” (Letter). Lancet ii: 685.

Perera F.P. (1992). “Molecular and genetic damage in humans from environmental pollution in Poland.” Nature 360: 256–258.

Perera F.P. Weinstein I.B. (1982). “Molecular epidemiology and carcinogens—DNA adduct detection: New approaches to studies of human cancer causation.” J. Chronic Dis. 35: 581–600.

Perl D.P. (1985). “Relationship of aluminum to Alzheimer's disease.” Environ. Health Perspect. Nov. 63: 149–153.

Perl D.P. (1989). “Genetics and Alzheimer's disease: Notes of an environment watcher (with apologies to L. Thomas).” Neurobiol. Aging 10: 444–446.

Perl D.P. Brody A.R. (1980). “Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons.” Science 208: 297–299.

Perl D.P. Gadjusek D.C. Garruto R. Yanagihara R.T. Gibbs C.J. (1982). “Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism with dementia of Guam.” Science 217:1053–1055.

Pezzoli G. Barbierei S. Ferrante C. Zecchinelli A. Foa V. (1989). “Parkinsonism due to n-hexane exposure.” (Letter). Lancet 2:874.

Poirer J. Kogan S. Gauthier S. (1991). “Environment, genetics and idiopathic Parkinson's disease.” Can. J. Neurol. Sci. 18:70–76.

Rajput A.H. Uitti R.J. Stern W. Laverty W. (1986). “Early onset Parkinson's disease in Saskatchewan—Environmental considerations for etiology.” Can. J. Neurol. Sci. Nov. 13(4):312–316.

Rajput A.H. Uitti R.J. Stern W. Laverty W. O'Donnel K. O'Donnell D. Yuen W.K. Dua A. (1987). “Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease.” Can. J. Neurol. Sci. 14:414–418.

Rocca W.A. Amaducci L. (1989). “The etiology of Alzheimer's disease: An epidemiologic point of view.” Neurobiol. Aging (Sept.-Oct.) 10:440–441; discussion 446–448.

Rosati B. Pina L. Granieri E. Aiello I. Tola R. Agnetti V. Pirisi A. DeBastiani P. (1977). “Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, southern Italy.” Acta. Neurol. Scand. 55:231–244.

Rosenberg R. (ed.). (1991). Comprehensive Neurology. Raven Press, New York.

Rothstein M. (1982). Biochemical Approaches to Aging. Academic Press, New York.

Rowland L.P. (1982). “Diverse forms of motor neuron diseases.” In: Human Motor Neuron Diseases ( Rowland L. , ed.). New York: Raven Press, pp. 1–13.

Schmalbruch H. Jensen H.-J.S. Bjaerg M. Kamieniecka Z. Kurland L. (1991). “A new mouse mutant with progressive motor neuronopathy.” J. Neuropathol. Exp. Neurol. 50:192–204.

Schoenberg B.S. Anderson D.W. Haerer A.F. (1985). “Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi.” Neurol. 35:841–845.

Schoenberg B.S. Osuntokun; B.O. Adeuja A.O. Bademosi O. Nottidge V. Anderson D.W. Haerer A.F. (1988). “Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: Door-to-door community studies.” Neurol. 38:645–646.

Semchuk K.M. Love E.J. Lee R.G. (1991). “Parkinson's disease and exposure to rural environmental factors: A population based case-control study.” Can. J. Neurol. Sci. 18:279–286.

Sienko D.G. Davis J.P. Taylor J.A. Brooks B.R. (1990). “Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community.” Arch. Neurol. 47:38–41.

Silbergeld E.K. (1992). “Mechanisms of lead neurotoxicity.” FASEB J. 16:1203–1206.

Silbergeld E.K. Calne D.B. (1981). “Animal models of Parkinsonism.” Pharmacol. Ther. 12:159–166.

Silbergeld E.K. Takeuchi Y. (1993). “Biochemical methods in neurobehavioral toxicology.” Environ. Research 60:74–75.

Simonsen L. Lund S.P. (1992). “A strategy for delineating risks due to exposure to neurotoxic chemicals.” Am. J. Indust. Med. 21:773–793.

Spencer P.S. (1990). “Guam ALS/Parkinsonism-dementia: A long-latency neurotoxic disorder caused by ‘slow toxin(s)’ in food?” Can. J. Neurol. Sci. 14:347–357.

St. George-Hyslop P.H. Myers R.H. Haines J.L. Farrer L.A. Polinsky R. Van Broeckhoven C. Goate A. Crapper McLachlan D.R. Orr H. Bruni A.C. Sorvi S. Rainero I. Foncin J.-F. Pollen D. Cantu J.-M. Tupler R. Voskresenskaya N. Mayeux R. Growdon J. Fried V.A. Myers R.H. Nee L. Backhovens H. Martin, J.-J. (Fad Collaborative Study Group). (1990). “Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder.” Nature 348:194–197.

Strong M.J. Hudson A.J. Alvad W.G. (1991). “Familial ALS 1850–1989: A statistical analysis of the world literature.” Can. J. Neurol. Sci. 18:45–58.

Tandan R. Bradley W.G. (1985a). “Anyotrophic lateral sclerosis. Part I: Clinical features, pathology, and ethical issues in management.” Ann. Neurol. 18:271–280.

Tandan R. Bradley W.G. (1985b). “Amyotrophic lateral sclerosis. Part II: Etiopathogenesis.” Ann. Neurol. 18:419–431.

Tang L.C. (1984). “A personal and scientific biography of Dr. George C. Cotzias.” Neurotoxicol. 5(1):5–12.

Tanner C.M. Langston J.W. (1990). “Do environmental toxins cause Parkinson's disease? A critical review.” Neurol. 40 (Suppl.): 17–30.

Taylor J.A. Davis J.P. (1989). “Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin.” J. Clin. Epidemiol. 42:569–575.

Ueda K. Kawano H. Hasuo Y. Fujishima M. (1992). “Prevalence and etiology of dementia in a Japanese community.” Stroke 23:798–803.

Vieregge P. Kleinhenz J. Fassi H.O. Jorg J. Kompf D. (1991). “Epidemiology and out-patient care in Parkinson's disease—Results from a pilot-study in Northern Germany (Schleswig-Holstein).” J. Neural. Transm. Suppl. 33:115–118.

Walker B. Goodwin N.J. Warren R.C. (1992). “Violence: A challenge to the public health community.” J. Natl. Med. Ass. 84:6–12.

Wang J.D. Huang C.C. Hwang Y.H. Chiang J.R. Lin J.M. Chen J.S. (1989). “Manganese induced parkinsonism: An outbreak due to an unrepaired ventilation control system in a ferromanganese smelter.” Br. J. Ind. Med. 46:856–859.

Weiss B. (1990). “Risk assessment: The insidious nature of neurotoxicity and the aging brain.” Neurotoxicol. 11:305–314.

White R.F. Feldman R.G. Travers P.H. (1990). “Neurobehavioral effects of toxicity due to metals, solvents, and insecticides.” Clin. Neuropharmacol. 13:392–412.

Williams D.B. Annegers J.F. Kokmen E. O'Brien P.C. Kurland L.T. (1991). “Brain injury and neurologic sequelae: A cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis.” Neurol. 41:1554–1557.